Prodia Diagnostic Line is trading 11.5% down at IDR 246 as profit-taking and cooling IPO enthusiasm extend the stock's post-listing correction.

  • Shares have fallen approximately 22% from the July 22 peak of IDR 320, marking a significant pullback from recent highs.
  • The current move appears to be a technical continuation of the post-IPO slide rather than a reaction to fresh company news or broader healthcare sector weakness.